Interested in Medipost Korea Cartistem? On this page, we have collected links for you, where you will receive the most necessary information about Medipost Korea Cartistem.
http://www.medi-post.com/cartistem/
CARTISTEM® – allogeneic umbilical cord blood-derived mesenchymal stem cells, is used for the treatment of knee cartilage defects in patients with Osteoarthritis (with ICRS grade* IV cartilage defect) caused by degeneration or repetitive trauma. *ICRS grade …
http://www.medi-post.com/
CARTISTEM ® – allogeneic umbilical cord blood-derived mesenchymal stem cells, is used for the treatment of knee cartilage defects in patients with Osteoarthritis (with ICRS grade* IV cartilage …Estimated Reading Time: 1 min
http://www.medi-post.com/intro/
MEDIPOST successfully commercialized allogeneic cord blood-derived mesenchymal stem cell product named CARTISTEM ®, as the world’s first regulatory approved allogeneic stem cell product approved by the Ministry of Food and Drug Safety (MFDS) of Korea …Estimated Reading Time: 5 mins
https://koreatimes.co.kr/www/tech/2019/12/694_279684.html
Dec 04, 2019 · SEONGNAM, Gyeonggi Province -- In 2014, Stem cell drug maker Medipost garnered attention after treating renowned football manager Guus Hiddink's knee with the company's cartilage …Estimated Reading Time: 5 mins
http://www.medi-post.com/stem-cell/
MEDIPOST Initiates Phase-2 Clinical Trial of CARTISTEM in Japan 2020.09.21 MEDIPOST’s CEO Dr Yang Yoonsun Named on the Forbes 2020 List of Asia’s Power Businesswomen 2020.09.16 MEDIPOST Completes Phase 2a Clinical Trial of NEUROSTEM for Alzheimer’s Disease 2020.07.07Estimated Reading Time: 30 secs
https://bciq.biocentury.com/products/cartistem
...Medipost said the Korea Food and Drug Administration approved Cartistem to treat osteoarthritis.
We hope you have found all the information you need about Medipost Korea Cartistem through the links above.
